Albert Bourla, CEO of Pfizer, said we may need annual Covid vaccinations

There will be a return to normal life within a year, Pfizer CEO and Chairman Albert Bourla said on Sunday, adding that annual Covid vaccinations will likely be required.

“Within a year, I think we’ll be able to get back to normal life,” Bourla said in an interview with ABC’s This Week.

Returning to normal life will come with reservations, he said: “I don’t think this means that the variants will get stuck, and I don’t think that this means that we should be able to live our lives without vaccinations.” said Bourla. “But that too remains to be seen.”

Bourla’s prediction of when normal life will resume coincides with that of Moderna CEO Stéphane Bancel. “As of today, in a year, I assume,” said Bancel of the Neue Zürcher Zeitung, according to Reuters, on Thursday when he was asked about his assessment of a return to normal life.

To do this, Pfizer’s Bourla suggested that annual vaccinations against the coronavirus will likely be required.

“The most likely scenario for me is that the virus will continue to bring new varieties to market because of its global spread,” Bourla said. “Also, we will have vaccines that will last at least a year and I think the most likely scenario is an annual vaccination, but we don’t really know, we have to wait for the dates.”

On Friday, the head of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky, distributing Pfizer and BioNTech’s Covid-19 booster vaccinations to people in high-risk professional and institutional settings, a move that overridden an advisory panel. Walensky approved the distribution of the booster to older Americans and adults with pre-existing conditions at least six months after their first series of vaccinations, in accordance with the advisory panel.

The World Health Organization strongly opposes the widespread introduction of booster vaccinations, saying that wealthier nations should give extra doses to countries with minimal vaccination rates.

Bourla said Sunday that it was “not right to decide whether or not to approve boosters” based on criteria other than “whether the boosters are needed”.

On Tuesday, Tom Frieden, former head of the CDC, criticized Moderna and Pfizer for not giving away vaccination-related intellectual property in order to speed up vaccination rates around the world.

“While Moderna and Pfizer are focused on selling expensive vaccines to rich countries, they are doing next to nothing to fill the global vaccine supply gap. Shameful, “said Frieden on Twitter.

Bourla said it was not a good idea to distribute intellectual property.

“Intellectual property created the thriving life sciences sector that was ready when the pandemic broke out,” said Bourla. “Without that, we wouldn’t be here to discuss whether or not we would be with us because we didn’t have vaccines… We are also very proud of what we have done. I do not know why [Frieden] uses these words. We are very proud. We have saved millions of lives. “

Pfizer sells vaccines at different prices to countries with different levels of wealth. Developing countries are buying vaccines at cost from Pfizer, Bourla said. And Bourla pointed out that Pfizer is selling a billion doses of vaccine to the US government at cost. The US government will then donate these doses of vaccine “free of charge and completely free of charge to the world’s poorest countries,” he said.


close






Don’t miss these tips!

We don’t spam! Read our privacy policy for more info.

adminhttps://mugenspace.com
You may contact us at admin@mugenspace.com for news feature or any other business enquiries

Latest articles

34 top toys for preschoolers

In partnership with Official Play Partner 2021 Toy Guide: Preschool Top Preschool toys of 2021 ...

23andMe to buy Lemonaid online pharmacy for $ 400 million

23andMe is buying another direct-to-consumer startup that wants to build on its genetic services with telemedicine. The company closed a deal to buy...

New Patches Resolve AMD Issues in Windows 11

This site may earn affiliate commissions from the links on this page. Terms of use. ...

Beyond Meat shares hit 52-week lows after lowering sales outlook for third quarter

Beyond Meat "Beyond Burger" patties made from plant-based meat substitutes are on sale on a shelf in New York City on November 15, 2019.Angela...

Categories

Related articles

Leave a reply

Please enter your comment!
Please enter your name here